Name: UMIN ID:
Unique ID issued by UMIN | UMIN000023710 |
---|---|
Receipt number | R000027314 |
Scientific Title | A multicenter, single arm phase 2 study to examine efficacy and cerebrospinal fluid transitivity of Osimertinib in leptomeningeal carcinomatosis (LMC) patients with non-small cell lung cancer harboring EGFR mutation |
Date of disclosure of the study information | 2016/10/01 |
Last modified on | 2016/10/03 08:04:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/08/22 17:02:07 | ||
2 | Update | 2016/10/03 08:04:44 | Recruitment status Anticipated trial start date |